Integration of AI with image-based genomics, consolidation towards integrated platforms, and growing focus on companion diagnostics bolster growthDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The ...
AML is a hematologic cancer that is clinically heterogeneous, with a wide range of clinical outcomes. DNA methylation changes are a hallmark of AML but are not routinely used as a criterion for risk ...
Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...
DUBLIN--(BUSINESS WIRE)--The "Cytogenetics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering. This report deals with cytogenetics ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
DNA methylation profiles in whole blood samples from 77 patients with CN-AML in The Cancer Genome Atlas (LAML cohort) were analyzed. Individual 5’-cytosine-phosphate-guanine-3’ (CpG) sites were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback